Logo

Course

Best of ACTHIV® 2026: Gazing into the Crystal Ball - What is the future of STI Prevention?

Details

Published Date: 09/15/2026

Expiration Date: 09/15/2027

CE Credit: CME: 0.75CNE: 0.75CPE: 0.75

Description

Selected by attendees and the program planning committee as one of the high-impact sessions of the ACTHIV® 2026 conference for the interprofessional HIV care team, this activity provides practical guidance on applying emerging evidence to the prevention and treatment of sexually transmitted infections, including doxycycline post-exposure prophylaxis (doxy PEP) for chlamydia prevention in cisgender women, management of Mycoplasma genitalium treatment failure, appropriate use of new antibiotics for gonorrhea, and an emerging treatment option for drug-resistant herpes simplex virus.

Presenter(s)

Ina Park,MD, MS

Ina Park, MD, is a Professor in the Department of Family and Community Medicine and the Department of Obstetrics and Gynecology at the University of California San Francisco School of Medicine. She currently serves as the Principal Investigator at the California Prevention Training Center and Medical Consultant for the Centers for Disease Control and Prevention (CDC)-Division of STD Prevention. Ina was a coauthor of the 2021 and forthcoming 2026 CDC STI Treatment Guidelines and is the author of the book Strange Bedfellows: Adventures in the Science, History and Surprising Secrets of STDs.  Her writing has also appeared in The New York Times and Scientific American.

Asa Radix,MD, MPH, FACP

Asa Radix, MD, is Chief Physician at Landspítali – The National University Hospital of Iceland, Associate Professor of Epidemiology at Columbia University Mailman School of Public Health, and Clinical Professor of Medicine at NYU Grossman School of Medicine. A board-certified internist and infectious disease specialist, Dr. Radix has more than three decades of experience providing HIV care in the United States, the Caribbean, and, most recently, Iceland. Their research focuses on HIV prevention, transgender health, sexual health, and healthcare disparities, with an emphasis on developing culturally responsive models of care.

Rupa Patel,MD, MPH, FIDSA 

Rupa R. Patel, MD, MPH, FIDSA is an infectious diseases physician in the Community Health Department at Whitman-Walker Health in Washington, D.C. She is the former CDC DHP Subject Matter Expert in PrEP/PEP and Guidelines Lead. Her research focuses on implementation strategies in non-clinic settings.

Learning Objectives

  • Describe efficacy of weekly doxy PEP for preventing chlamydia in cisgender women.
  • Develop a strategy for using antibiotics in patients experiencing M. genitalium treatment failure.
  • Appropriately utilize two new antibiotics for gonorrhea.
  • Review a potential new treatment option for drug resistant HSV.

Continuing Education Credit Information